|
1
|
Akram M, Iqbal M, Daniyal M and Khan AU:
Awareness and current knowledge of breast cancer. Biol Res.
50:332017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
de la Cruz-Merino L, Chiesa M, Caballero
R, Rojo F, Palazón N, Carrasco FH and Sánchez-Margalet V: Breast
cancer immunology and immunotherapy: Current status and future
perspectives. Int Rev Cell Mol Biol. 331:12017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gooden MJ, de Bock GH, Leffers N, Daemen T
and Nijman HW: The prognostic influence of tumour-infiltrating
lymphocytes in cancer: A systematic review with meta-analysis. Br J
Cancer. 105:93–103. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mahmoud SM, Paish EC, Powe DG, Macmillan
RD, Grainge MJ, Lee AH, Ellis IO and Green AR: Tumor-infiltrating
CD8+ lymphocytes predict clinical outcome in breast cancer. J Clin
Oncol. 29:1949–1955. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu S, Foulkes WD, Leung S, Gao D, Lau S,
Kos Z and Nielsen TO: Prognostic significance of FOXP3+ tumor
infiltrating lymphocytes in breast cancer depends on estrogen
receptor and human epidermal growth factor receptor-2 expression
status and concurrent cytotoxic T-cell infiltration. Breast Cancer
Res. 16:4322014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Seo AN, Lee HJ, Kim EJ, Kim HJ, Jang MH,
Lee HE, Kim YJ, Kim JH and Park SY: Tumour-infiltrating CD8+
lymphocytes as an independent predictive factor for pathological
complete response to primary systemic therapy in breast cancer. Br
J Cancer. 109:2705–2713. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Denkert C, Loibl S, Noske A, Roller M,
Muller BM, Komor M, Budczies J, Darb-Esfahani S, Kronenwett R,
Hanusch C, et al: Tumor-associated lymphocytes as an independent
predictor of response to neoadjuvant chemotherapy in breast cancer.
J Clin Oncol. 28:105–113. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Spranger S, Sivan A, Corrales L and
Gajewski TF: Tumor and host factors controlling antitumor immunity
and efficacy of cancer immunotherapy. Adv Immunol. 130:75–93. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qin Q, Miao J, Wang S, Yu Q, Li M, He F
and Wang G: Association between intestinal flora and immunity in
middle-aged and aged people by PCR-DGGE. Wei Sheng Yan Jiu.
46:40–45. 2017.(In Chinese). PubMed/NCBI
|
|
10
|
Hooper LV, Littman DR and Macpherson AJ:
Interactions between the microbiota and the immune system. Science.
336:1268–1273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ivanov II and Honda K: Intestinal
commensal microbes as immune modulators. Cell Host Microbe.
12:496–508. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Abt MC, Osborne LC, Monticelli LA, Doering
TA, Alenghat T, Sonnenberg GF, Paley MA, Antenus M, Williams KL,
Erikson J, et al: Commensal bacteria calibrate the activation
threshold of innate antiviral immunity. Immunity. 37:158–170. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ganal SC, Sanos SL, Kallfass C, Oberle K,
Johner C, Kirschning C, Lienenklaus S, Weiss S, Staeheli P, Aichele
P and Diefenbach A: Priming of natural killer cells by nonmucosal
mononuclear phagocytes requires instructive signals from commensal
microbiota. Immunity. 37:171–186. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Iida N, Dzutsev A, Stewart CA, Smith L,
Bouladoux N, Weingarten RA, Molina DA, Salcedo R, Back T, Cramer S,
et al: Commensal bacteria control cancer response to therapy by
modulating the tumor microenvironment. Science. 342:967–970. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dingemanse C, Belzer C, van Hijum SA,
Günthel M, Salvatori D, den Dunnen JT, Kuijper EJ, Devilee P, de
Vos WM, van Ommen GB and Robanus-Maandag EC: Akkermansia
muciniphila and Helicobacter typhlonius modulate intestinal tumor
development in mice. Carcinogenesis. 36:1388–1396. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Omar Al-Hassi H, Ng O and Brookes M:
Tumour-associated and non-tumour-associated microbiota in
colorectal cancer. Gut. 67:3952018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Peled JU, Devlin SM, Staffas A, Lumish M,
Khanin R, Littmann ER, Ling L, Kosuri S, Maloy M, Slingerland JB,
et al: Intestinal microbiota and relapse after hematopoietic-cell
transplantation. J Clin Oncol. 35:1650–1659. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hammond ME, Hayes DF, Dowsett M, Allred
DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS,
Hayes M, et al: American society of clinical oncology/college of
American pathologists guideline recommendations for
immunohistochemical testing of estrogen and progesterone receptors
in breast cancer. J Clin Oncol. 28:2784–2795. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wolff AC, Hammond MEH, Allison KH, Harvey
BE, Mangu PB, Bartlett JMS, Bilous M, Ellis IO, Fitzgibbons P,
Hanna W, et al: Human epidermal growth factor receptor 2 testing in
breast cancer: American society of clinical oncology/college of
American pathologists clinical practice guideline focused update. J
Clin Oncol. 36:2105–2122. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ogston KN, Miller ID, Payne S, Hutcheon
AW, Sarkar TK, Smith I, Schofield A and Heys SD: A new histological
grading system to assess response of breast cancers to primary
chemotherapy: prognostic significance and survival. Breast.
12:320–327. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Salgado R, Denkert C, Demaria S, Sirtaine
N, Klauschen F, Pruneri G, Wienert S, Van den Eynden G, Baehner FL,
Penault-Llorca F, et al: The evaluation of tumor-infiltrating
lymphocytes (TILs) in breast cancer: recommendations by an
International TILs Working Group 2014. Ann Oncol. 26:259–271. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hida AI and Ohi Y: Evaluation of
tumor-infiltrating lymphocytes in breast cancer; proposal of a
simpler method. Ann Oncol. 26:23512015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Magoč T and Salzberg SL: FLASH: Fast
length adjustment of short reads to improve genome assemblies.
Bioinformatics. 27:2957–2963. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Caporaso JG, Kuczynski J, Stombaugh J,
Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich
JK, Gordon JI, et al: QIIME allows analysis of high-throughput
community sequencing data. Nat Methods. 7:335–336. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bokulich NA, Subramanian S, Faith JJ,
Gevers D, Gordon JI, Knight R, Mills DA and Caporaso JG:
Quality-filtering vastly improves diversity estimates from Illumina
amplicon sequencing. Nat Methods. 10:57–59. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Edgar and Robert C: UPARSE: highly
accurate OTU sequences from microbial amplicon reads. Nat Methods.
10:996–998. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Q, Garrity GM, Tiedje JM and Cole JR:
Naive Bayesian classifier for rapid assignment of rRNA sequences
into the new bacterial taxonomy. Appl Environ Microbiol.
73:5261–5267. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
DeSantis TZ, Hugenholtz P, Larsen N, Rojas
M, Brodie EL, Keller K, Huber T, Dalevi D, Hu P and Andersen GL:
Greengenes, a chimera-checked 16S rRNA gene database and workbench
compatible with ARB. Appl Environ Microbiol. 72:5069–5072. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
White JR, Nagarajan N and Pop M:
Statistical methods for detecting differentially abundant features
in clinical metagenomic samples. PLoS Comput Biol. 5:e10003522009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cotillard A, Kennedy SP, Kong LC, Prifti
E, Pons N, Le Chatelier E, Almeida M, Quinquis B, Levenez F,
Galleron N, et al: Dietary intervention impact on gut microbial
gene richness. Nature. 500:585–588. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Larsen N, Vogensen FK, van den Berg FW,
Nielsen DS, Andreasen AS, Pedersen BK, Al-Soud WA, Sørensen SJ,
Hansen LH and Jakobsen M: Gut microbiota in human adults with type
2 differs from non-diabetic adults. PLoS One. 5:e908552000.
|
|
32
|
Markle JG, Frank DN, Mortin-Toth S,
Robertson CE, Feazel LM, Rolle-Kampczyk U, von Bergen M, McCoy KD,
Macpherson AJ and Danska JS: Sex differences in the gut microbiome
drive hormone-dependent regulation of autoim munity. Science.
339:1084–1088. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Koeth RA, Wang Z, Levison BS, Buffa JA,
Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, et al: Intestinal
microbiota metabolism of L carnitine, a nutrient in red meat
promotes atherosclerosis. Nat Med. 19:576–585. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang
X, Jia W, Cai S and Zhao L: Structural segregation of gut
microbiota between colorectal cancer patients and healthy
volunteers. ISME J. 6:320–329. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vujkovic-Cvijin I, Dunham RM, Iwai S,
Maher MC, Albright RG, Broadhurst MJ, Hernandez RD, Lederman MM,
Huang Y, Somsouk M, et al: Dysbiosis of the gut microbiota is
associated with HIV disease progression and tryptophan catabolism.
Sci Transl Med. 5:193ra912013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fox JG, Feng Y, Theve EJ, Raczynski AR,
Fiala JLA, Doernte AL, Williams M, McFaline JL, Essigmann JM,
Schauer DB, et al: Gut microbes define liver cancer risk in mice
exposed to chemical and viral trans genic hepatocarcinogens. Gut.
59:88–97. 2009. View Article : Google Scholar
|
|
37
|
Wang Z, Klipfell E, Bennett BJ, Koeth R,
Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, et al:
Gut flora metabolism of phosphatidylcholine promotes cardiovascular
disease. Nature. 472:57–63. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Goedert JJ, Jones G, Hua X, Xu X, Yu G,
Flores R, Falk RT, Gail MH, Shi J, Ravel J and Feigelson HS:
Investigation of the association between the fecal microbiota and
breast cancer in postmenopausal women: a population-based
case-control pilot study. J Natl Cancer Inst. 107:djv1472015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Luu TH, Michel C, Bard JM, Dravet F, Nazih
H and Bobin-Dubigeon C: Intestinal proportion of Blautia sp. is
associated with clinical stage and histoprognostic grade in
patients with early-stage breast cancer. Nutr Cancer. 69:267–275.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fuhrman BJ, Feigelson HS, Flores R, Gail
MH, Xu X, Ravel J and Goedert JJ: Associations of the fecal
microbiome with urinary estrogens and estrogen metabolites in
postmenopausal women. J Clin Endocrinol Metab. 99:4632–4640. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Flores R, Shi J, Fuhrman B, Xu X, Veenstra
TD, Gail MH, Gajer P, Ravel J and Goedert JJ: Fecal microbial
determinants of fecal and systemic estrogens and estrogen
metabolites: A cross-sectional study. J Transl Med. 10:2532012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Estrogen excretion patterns and plasma
levels in vegetarian and omnivorous women. Nutr Rev. 41:180–183.
1983.PubMed/NCBI
|
|
43
|
Goldin BR, Adlercreutz H, Gorbach SL,
Warram JH, Dwyer JT, Swenson L and Woods MN: Estrogen excretion
patterns and plasma levels in vegetarian and omnivorous women. N
Engl J Med. 307:1542–1547. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Savas P, Salgado R, Denkert C, Sotiriou C,
Darcy PK, Smyth MJ and Loi S: Clinical relevance of host immunity
in breast cancer: from TILs to the clinic. Nat Rev Clin Oncol.
13:228–241. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Viaud S, Saccheri F, Mignot G, Yamazaki T,
Daillère R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ,
et al: The intestinal microbiota modulates the anticancer immune
effects of cyclophosphamide. Science. 342:971–976. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Galon J, Costes A, Sanchez-Cabo F,
Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M,
Berger A, Wind P, et al: Type, density, and location of immune
cells within human colorectal tumors predict clinical outcome.
Science. 313:1960–1964. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Rastogi P, Anderson SJ, Bear HD, Geyer CE,
Kahlenberg MS, Robidoux A, Margolese RG, Hoehn JL, Vogel VG, Dakhil
SR, et al: Preoperative chemotherapy: Updates of national surgical
adjuvant breast and bowel project protocols B-18 and B-27. J Clin
Oncol. 26:778–785. 2008. View Article : Google Scholar : PubMed/NCBI
|
